Article
Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patients.
Lung cancer (Amsterdam, Netherlands) - 1 Aug 2012
Park Heae Surng, Lee June Koo, Kim Dong-Wan, Kulig Kimary, Kim Tae Min, Lee Se-Hoon, Jeon Yoon-Kyung, Chung Doo Hyun, Heo Dae Seog
Abstract excerpt
Fluorescence in situ hybridization (FISH) is currently used to detect non-small cell lung cancer (NSCLC) patients with anaplastic lymphoma kinase (ALK) gene rearrangement, who are candidates for ALK inhibitor therapy. However, FISH may not be a practical method for screening for ALK-positive patients in a large population due to its cost and difficulty in interpretation. We investigated the role of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
